598 research outputs found

    Colonization and persistence of Crangonyx pseudogracilis (Bousfield 1958) in temporary pools

    Get PDF
    Crangonyctid amphipods occupy temporary habitats across northeastern North America, but they are mostly known as permanent-water species. Crangonyx pseudogracilis (Bousfield 1958) is found at high densities in temporary pools in western New York, but the means by which it persists are not well understood. Our objectives were to: 1) assess the dispersal abilities of C. pseudogracilis, 2) explore its ability to descend through inundated porous substrates, 3) assess whether its life cycle and brood releases are related to survival through the dry season, and 4) find their dry-season refugia and measure the period for which they can survive desiccation. During periods of inundation, C. pseudogracilis was found in the top 15 cm of soil in holes \u3c10 m from pools. After pools dried in mid-June or early July, C. pseudogracilis was not found in the soil to a depth of 45 cm, even when rains temporarily refilled the pools. In the laboratory, small C. pseudogracilis descended easily through substrates with ≥ 0.7-mm pore radii but large (≥ 7 mm) and ovigerous C. pseudogracilis were unable to descend. In the field, ovigerous females were found from mid-March until late May. The previous year’s generation of large and ovigerous individuals began dying in May and was gone by the end June. In the laboratory, C. pseudogracilis survived in damp soil (51% average free moisture content) for 15 wk. Crangonyx pseudogracilis lacks specialized strategies for survival in temporary waters (e.g., resting eggs, dormant juvenile stages, active burrowing), but has ecological traits well suited for temporary pools and similar environment

    Multiaxis, Lightweight, Computer-Controlled Exercise System

    Get PDF
    The multipurpose, multiaxial, isokinetic dynamometer (MMID) is a computer-controlled system of exercise machinery that can serve as a means for quantitatively assessing a subject s muscle coordination, range of motion, strength, and overall physical condition with respect to a wide variety of forces, motions, and exercise regimens. The MMID is easily reconfigurable and compactly stowable and, in comparison with prior computer-controlled exercise systems, it weighs less, costs less, and offers more capabilities. Whereas a typical prior isokinetic exercise machine is limited to operation in only one plane, the MMID can operate along any path. In addition, the MMID is not limited to the isokinetic (constant-speed) mode of operation. The MMID provides for control and/or measurement of position, force, and/or speed of exertion in as many as six degrees of freedom simultaneously; hence, it can accommodate more complex, more nearly natural combinations of motions and, in so doing, offers greater capabilities for physical conditioning and evaluation. The MMID (see figure) includes as many as eight active modules, each of which can be anchored to a floor, wall, ceiling, or other fixed object. A cable is payed out from a reel in each module to a bar or other suitable object that is gripped and manipulated by the subject. The reel is driven by a DC brushless motor or other suitable electric motor via a gear reduction unit. The motor can be made to function as either a driver or an electromagnetic brake, depending on the required nature of the interaction with the subject. The module includes a force and a displacement sensor for real-time monitoring of the tension in and displacement of the cable, respectively. In response to commands from a control computer, the motor can be operated to generate a required tension in the cable, to displace the cable a required distance, or to reel the cable in or out at a required speed. The computer can be programmed, either locally or via a remote terminal, to support exercises in one or more of the usual exercise modes (isometric, isokinetic, or isotonic) along complex, multiaxis trajectories. The motions of, and forces applied by, the subject can be monitored in real time and recorded for subsequent evaluation. Through suitable programming, the exercise can be adjusted in real time according to the physical condition of the subject. The remote- programming capability makes it possible to connect multiple exercise machines into a network for supervised exercise by multiple subjects or even for competition by geographically dispersed subjects

    Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors

    Get PDF
    Background: Recent data have raised concern about the clinical efficacy of aromatase inhibitors in overweight and/or obese breast cancer patients. We report in vivo aromatase inhibition and plasma and tissue oestrogen levels in relation to body mass index (BMI) status among breast cancer patients treated with different aromatase inhibitors. Methods: We compared data on in vivo aromatase inhibition (64 patients) as well as plasma and tissue oestrogen levels from patients participating in our studies to BMI values. Results: We found a weak positive correlation between pretreatment aromatisation level and BMI (n = 64; R = 0.236; p = 0.060) but no correlation between on-treatment aromatisation levels or percentage aromatase inhibition and BMI within patient subgroups treated with any of a panel of aromatase inhibitors. Pre-treatment levels of plasma estradiol (p < 0.001), estrone (p = 0.001) and estrone sulphate (p = 0.002) correlated to BMI. While on-treatment levels of plasma estrane sulphate correlated to BMI in patients on letrozole (R = 0.601; p = 0.001; n = 25 for all) or anastrozole (n = 12; R = 0.611; p = 0.035) therapy, letrozole suppressed plasma estrone sulphate more than anastrozole independent of BMI. No correlation between on-treatment tumour oestrogen levels and BMI was recorded. Conclusions: Our unique data do not support a lack of effective aromatase inhibition in overweight patients or therefore a need for alternative therapy. The higher levels of estrogens in overweight postmenopausal breast cancer patients before and during aromatase inhibition may be due to effects of BMI on oestrogen metabolism rather than aromatisation

    Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors

    Get PDF
    Background: Recent data have raised concern about the clinical efficacy of aromatase inhibitors in overweight and/or obese breast cancer patients. We report in vivo aromatase inhibition and plasma and tissue oestrogen levels in relation to body mass index (BMI) status among breast cancer patients treated with different aromatase inhibitors. Methods: We compared data on in vivo aromatase inhibition (64 patients) as well as plasma and tissue oestrogen levels from patients participating in our studies to BMI values. Results: We found a weak positive correlation between pretreatment aromatisation level and BMI (n = 64; R = 0.236; p = 0.060) but no correlation between on-treatment aromatisation levels or percentage aromatase inhibition and BMI within patient subgroups treated with any of a panel of aromatase inhibitors. Pre-treatment levels of plasma estradiol (p < 0.001), estrone (p = 0.001) and estrone sulphate (p = 0.002) correlated to BMI. While on-treatment levels of plasma estrane sulphate correlated to BMI in patients on letrozole (R = 0.601; p = 0.001; n = 25 for all) or anastrozole (n = 12; R = 0.611; p = 0.035) therapy, letrozole suppressed plasma estrone sulphate more than anastrozole independent of BMI. No correlation between on-treatment tumour oestrogen levels and BMI was recorded. Conclusions: Our unique data do not support a lack of effective aromatase inhibition in overweight patients or therefore a need for alternative therapy. The higher levels of estrogens in overweight postmenopausal breast cancer patients before and during aromatase inhibition may be due to effects of BMI on oestrogen metabolism rather than aromatisation.publishedVersio

    Adrenal insufficiency

    Get PDF
    This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of adrenal insufficiency

    The distance and neutral environment of the massive stellar cluster Westerlund 1

    Get PDF
    The goal of this study is to determine a distance to Westerlund 1 independent of the characteristics of the stellar population and to study its neutral environment, using observations of atomic hydrogen. The HI observations are taken from the Southern Galactic Plane Survey to study HI absorption in the direction of the HII region created by the members of Westerlund 1 and to investigate its environment as observed in the HI line emission. A Galactic rotation curve was derived using the recently revised values for the Galactic centre distance of R⊙=7.6R_\odot = 7.6 kpc, and the velocity of the Sun around the Galactic centre of Θ⊙=214\Theta_\odot = 214 km s−1^{-1}. The newly determined rotation model leads us to derive a distance of 3.9±0.73.9\pm 0.7 kpc to Westerlund 1, consistent with a location in the Scutum-Crux Arm. Included in this estimate is a very careful investigation of possible sources of error for the Galactic rotation curve. We also report on small expanding HI features around the cluster with a maximum dynamic age of 600,000 years and a larger bubble which has a minimum dynamic age of 2.5 million years. Additionally we re-calculated the kinematic distances to nearby HII regions and supernova remnants based on our new Galaxic rotation curve. We propose that in the early stages of the development of Wd 1 a large interstellar bubble of diameter about 50 pc was created by the cluster members. This bubble has a dynamic age similar to the age of the cluster. Small expanding bubbles, with dynamical ages ∼0.6\sim 0.6 Myr are found around Wd 1, which we suggest consist of recombined material lost by cluster members through their winds.Comment: 8 pages, accepted for publication in A&
    • …
    corecore